332 related articles for article (PubMed ID: 29322868)
1. In silico approaches to evaluate the molecular properties of organophosphate compounds to inhibit acetylcholinesterase activity in housefly.
Marimuthu P; Lee YJ; Kim B; Seo SS
J Biomol Struct Dyn; 2019 Feb; 37(2):307-320. PubMed ID: 29322868
[TBL] [Abstract][Full Text] [Related]
2. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
Gurung AB; Aguan K; Mitra S; Bhattacharjee A
J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
[TBL] [Abstract][Full Text] [Related]
3. A mechanism-based 3D-QSAR approach for classification and prediction of acetylcholinesterase inhibitory potency of organophosphate and carbamate analogs.
Lee S; Barron MG
J Comput Aided Mol Des; 2016 Apr; 30(4):347-63. PubMed ID: 27055524
[TBL] [Abstract][Full Text] [Related]
4. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
Lee S; Barron MG
Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationship of organophosphate compounds based on molecular interaction fields descriptors.
Zhao J; Yu S
Environ Toxicol Pharmacol; 2013 Mar; 35(2):228-34. PubMed ID: 23348103
[TBL] [Abstract][Full Text] [Related]
7. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
9. The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays.
Zhang Y; Zhang S; Xu G; Yan H; Pu Y; Zuo Z
Mol Biosyst; 2016 Nov; 12(12):3734-3742. PubMed ID: 27801451
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors.
Gharaghani S; Khayamian T; Ebrahimi M
SAR QSAR Environ Res; 2013; 24(9):773-94. PubMed ID: 23863115
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
12. Exploring molecular structural requirement for AChE inhibition through multi-chemometric and dynamics simulation analyses.
Hossain T; Saha A; Mukherjee A
J Biomol Struct Dyn; 2018 Apr; 36(5):1274-1285. PubMed ID: 28417668
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the crucial molecular properties of a series of Benzothiazole Hydrazone inhibitors that targets anti-apoptotic Bcl-xL protein.
Marimuthu P; Balasubramanian PK; Singaravelu K
J Biomol Struct Dyn; 2018 Aug; 36(10):2654-2667. PubMed ID: 28793831
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease.
El Khatabi K; El-Mernissi R; Aanouz I; Ajana MA; Lakhlifi T; Khan A; Wei DQ; Bouachrine M
J Mol Model; 2021 Sep; 27(10):302. PubMed ID: 34581863
[TBL] [Abstract][Full Text] [Related]
15. QSAR analyses of organophosphates for insecticidal activity and its in-silico validation using molecular docking study.
Niraj RR; Saini V; Kumar A
Environ Toxicol Pharmacol; 2015 Nov; 40(3):886-94. PubMed ID: 26492451
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
17. Dynamic structure based pharmacophore modeling of the Acetylcholinesterase reveals several potential inhibitors.
Shiri F; Pirhadi S; Ghasemi JB
J Biomol Struct Dyn; 2019 Apr; 37(7):1800-1812. PubMed ID: 29695192
[TBL] [Abstract][Full Text] [Related]
18. In-silico and in-vitro evaluation of human acetylcholinesterase inhibition by organophosphates.
Ranjan A; Chauhan A; Jindal T
Environ Toxicol Pharmacol; 2018 Jan; 57():131-140. PubMed ID: 29272792
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations.
Malik R; Choudhary BS; Srivastava S; Mehta P; Sharma M
J Biomol Struct Dyn; 2017 Nov; 35(15):3268-3284. PubMed ID: 27782777
[TBL] [Abstract][Full Text] [Related]
20. The reactivation of tabun-inhibited mutant AChE with Ortho-7: steered molecular dynamics and quantum chemical studies.
Lo R; Chandar NB; Ghosh S; Ganguly B
Mol Biosyst; 2016 Apr; 12(4):1224-31. PubMed ID: 26879641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
